Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

IMPORTANCE: Numerous cancer drugs have received accelerated approval from the US Food and Drug Administration (FDA) based on clinical trial outcomes that are otherwise not acceptable for traditional FDA approval; the accelerated approval process allows outcomes based on surrogate measures that are o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA Intern Med
Hauptverfasser: Cherla, Avi, Naci, Huseyin, Kesselheim, Aaron S., Gyawali, Bishal, Mossialos, Elias
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Medical Association 2021
Schlagworte:
Original Investigation
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7900925/
https://ncbi.nlm.nih.gov/pubmed/33616607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2020.8441
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge